(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid

C43H62N6O12 — CID 148810944

IUPAC(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid
SMILESC[C@H](CCC(=O)OCCOCCOCCOCCN=[N+]=[N-])C1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)[C@H](CC(=O)O)Cc5ccc([N+](=O)[O-])c6nonc56)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C43H62N6O12/c1-27(4-11-38(52)59-23-22-58-21-20-57-19-18-56-17-16-45-48-44)33-8-9-34-32-7-6-30-26-31(12-14-42(30,2)35(32)13-15-43(33,34)3)60-41(53)29(25-37(50)51)24-28-5-10-36(49(54)55)40-39(28)46-61-47-40/h5,10,27,29-35H,4,6-9,11-26H2,1-3H3,(H,50,51)/t27-,29+,30-,31-,32+,33?,34+,35+,42+,43-/m1/s1
InChIKeyOPWXUCLCODZDAV-VVIFZUNGSA-N
MW855.00 g/mol
LogP7.65
Rot. Bonds23

About (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid

(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid (PubChem CID 148810944) has the molecular formula C43H62N6O12 and a molecular weight of 855.00 g/mol. Its IUPAC name is (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid.

Molecular Properties

Compound Name(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid
PubChem CID148810944
Molecular FormulaC43H62N6O12
Molecular Weight855.00 g/mol
Exact Mass854.44
IUPAC Name(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid
SMILESC[C@H](CCC(=O)OCCOCCOCCOCCN=[N+]=[N-])C1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)[C@H](CC(=O)O)Cc5ccc([N+](=O)[O-])c6nonc56)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C43H62N6O12/c1-27(4-11-38(52)59-23-22-58-21-20-57-19-18-56-17-16-45-48-44)33-8-9-34-32-7-6-30-26-31(12-14-42(30,2)35(32)13-15-43(33,34)3)60-41(53)29(25-37(50)51)24-28-5-10-36(49(54)55)40-39(28)46-61-47-40/h5,10,27,29-35H,4,6-9,11-26H2,1-3H3,(H,50,51)/t27-,29+,30-,31-,32+,33?,34+,35+,42+,43-/m1/s1
InChIKeyOPWXUCLCODZDAV-VVIFZUNGSA-N
XLogP7.65
TPSA248.41 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds23
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500855.00
LogP ≤ 57.65
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Azido_group', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}

Analyze (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid?
The IUPAC name of (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid (CID 148810944) is (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid.
What is the SMILES notation for (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid?
The canonical SMILES for (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid is C[C@H](CCC(=O)OCCOCCOCCOCCN=[N+]=[N-])C1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)[C@H](CC(=O)O)Cc5ccc([N+](=O)[O-])c6nonc56)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid?
The InChIKey is OPWXUCLCODZDAV-VVIFZUNGSA-N. The full InChI is InChI=1S/C43H62N6O12/c1-27(4-11-38(52)59-23-22-58-21-20-57-19-18-56-17-16-45-48-44)33-8-9-34-32-7-6-30-26-31(12-14-42(30,2)35(32)13-15-43(33,34)3)60-41(53)29(25-37(50)51)24-28-5-10-36(49(54)55)40-39(28)46-61-47-40/h5,10,27,29-35H,4,6-9,11-26H2,1-3H3,(H,50,51)/t27-,29+,30-,31-,32+,33?,34+,35+,42+,43-/m1/s1.
What are the key properties of (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid?
(3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid has a molecular weight of 855.00 g/mol, XLogP of 7.65, 23 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-4-[[(3R,5R,8R,9S,10S,13R,14S)-17-[(2R)-5-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)methyl]-4-oxobutanoic acid is sourced from PubChem (CID 148810944), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).